CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 948 enrolled
Drug / intervention
Rectal Indomethacin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02116309
NCT02116309N/ACompleted
CompareCT.gov

A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients

Johns Hopkins University·interventional·Posted Apr 16, 2014·Updated Nov 1, 2017

In Brief

A clinical study evaluating Rectal Indomethacin and Epinephrine for Post-ERCP Acute Pancreatitis. Completed, enrolled 948 participants across 4 sites in 2 countries.

Detailed Summary

This research is being done to see if using a combination of rectal indomethacin and epinephrine spray during endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-ERCP Acute Pancreatitis
CountriesIndia, United States
CollaboratorsAmerican Society for Gastrointestinal Endoscopy, Asian Institute of Gastroenterology, India, Post Graduate Institute of Medical Education and Research, Chandigarh, Apollo Gleneagles Hospitals, Kolkata

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 16, 2014
Enrollment StartAug 1, 2014
Primary CompletionDec 2, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.2 years ago

Interventions

Rectal Indomethacindrug

Epinephrinedrug